Atara Biotherapeutics, Inc. · NASDAQ:ATRA
Grant-Huerta Yanina sold 2,414 Atara Biotherapeutics, Inc. shares (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Grant-Huerta Yanina (Chief Accounting Officer) sold 2,414 Atara Biotherapeutics, Inc. shares at US$9.13 for US$22,040, leaving 49,636 shares. Filed May 20, 2026 (Form 4).
- Sold
- 2,414 shares
- Price
- US$9.13
- Value
- US$22,040
- Holding after
- 49,636 shares
- Trading plan
- No
- Role
- Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Sale | 2,414 | US$9.13 | 49,636 | Direct |
Source
Related
- Atara Biotherapeutics, Inc.
- Grant-Huerta Yanina
- Atara Biotherapeutics, Inc. shareholders
- Form 4 · Cherry Brian N · Sep 4, 2026
- Form 4 · Nguyen AnhCo · Aug 26, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Form 4 · Redmile Group, LLC · Jul 24, 2026
- Schedule 13D/A · Redmile Group, LLC · Jul 24, 2026